We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 109 results
  1. Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review

    The monoclonal antibodies (mAbs) blocking the calcitonin-gene related peptide (CGRP) pathway, collectively called here “anti-CGRP/rec mAbs”, have...

    Jean Schoenen, Annelies Van Dycke, ... Koen Paemeleire in The Journal of Headache and Pain
    Article Open access 01 August 2023
  2. COVID-19 and MIS-C treatment in children—results from an international survey

    Children have been mostly excluded from COVID-19 clinical trials, and, as a result, most medicines approved for COVID-19 have no pediatric...

    Daniele Donà, Chiara Minotti, ... Edward Kabeja in European Journal of Pediatrics
    Article Open access 06 September 2023
  3. Functional effects of immune complexes formed between pembrolizumab and patient-generated anti-drug antibodies

    The PD-1-targeting IgG 4 antibody pembrolizumab has significant anti-tumor activity in a proportion of stage IV melanoma patients. A subset of...

    Barry D. Hock, Judith L. McKenzie, ... Margaret J. Currie in Cancer Immunology, Immunotherapy
    Article 16 June 2020
  4. Translating B cell immunology to the treatment of antibody-mediated allograft rejection

    Antibody-mediated rejection (AMR), including chronic AMR (cAMR), causes ~50% of kidney allograft losses each year. Despite attempts to develop...

    Peter S. Heeger, Maria Carrera Haro, Stanley Jordan in Nature Reviews Nephrology
    Article 02 January 2024
  5. Respiratory Syncytial Virus Infection: An Update

    Respiratory syncytial virus (RSV) is a highly contagious respiratory virus that can cause mild to severe illness in children. It is the leading cause...

    Akshita Soni, S. K. Kabra, Rakesh Lodha in Indian Journal of Pediatrics
    Article 16 June 2023
  6. Managing Waldenström’s macroglobulinemia with BTK inhibitors

    Bruton’s tyrosine kinase (BTK) inhibition is one of the treatment standards for patients with relapsed/refractory Waldenström’s macroglobulinemia...

    Christian Buske, Wojciech Jurczak, ... Meletios A. Dimopoulos in Leukemia
    Article Open access 19 November 2022
  7. Outpatient Management of COVID-19: A Primer for the Dermatologist

    Purpose of Review

    To summarize diagnostic and therapeutic management of COVID-19 in the outpatient setting for dermatologists.

    Recent Findings ...
    Sonia Wang, Joel M. Gelfand, Cassandra Calabrese in Current Dermatology Reports
    Article 20 August 2022
  8. Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients

    Purpose of Review

    In this review, we aim to summarize the evolution of care for the solid organ transplant recipient (SOTR) with COVID-19 disease,...

    Rachel Sigler, Victor Chen, Nancy Law in Current Transplantation Reports
    Article Open access 31 May 2022
  9. 25 years of biologic DMARDs in rheumatology

    Marc Feldmann, Ravinder N. Maini, ... Tsutomu Takeuchi in Nature Reviews Rheumatology
    Article 02 November 2023
  10. Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium

    Background

    Histone modifications play a critical role in chromatin remodelling and regulate gene expression in health and disease. Histone...

    Julia Sánchez-Ceinos, Shafaat Hussain, ... Francesco Cosentino in Cardiovascular Diabetology
    Article Open access 05 April 2024
  11. The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

    Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults....

    Joseph B. Domachowske, Evan J. Anderson, Mitchell Goldstein in Infectious Diseases and Therapy
    Article Open access 03 March 2021
  12. Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases

    Purpose of Review

    The use of biologic therapies has risen exponentially over recent years, allowing for unprecedented disease control within numerous...

    Timothy G. Chow, Lauren E. Franzblau, David A. Khan in Current Allergy and Asthma Reports
    Article 28 October 2022
  13. Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies

    Background and Objectives

    Depletion of B cells is shown to be clinically effective for rheumatoid arthritis (RA) treatment. Although B-cell depletion...

    S Sajith Kumar, Bhavani Shankara Bagepally, Akhil Sasidharan in Clinical Drug Investigation
    Article 09 January 2023
  14. Lp(a): a New Pathway to Target?

    Purpose of Review

    Over the past decades, genetic and observational evidence has positioned lipoprotein(a) as novel important and independent risk...

    Nick S. Nurmohamed, Jordan M. Kraaijenhof, Erik S. G. Stroes in Current Atherosclerosis Reports
    Article Open access 06 September 2022
  15. The role of minimal residual disease and serum free light chain ratio in the management of multiple myeloma

    Multiple myeloma (MM) denotes a cancerous growth characterized by abnormal proliferation of plasma cells. Growing evidence suggests that the...

    Long-Ying Zhu, Qi-Lei Hu, ... Zuo-Jie Li in Discover Oncology
    Article Open access 15 June 2024
  16. Recent Advances in the Management of Cluster Headache

    Purpose of review

    Among the spectrum of pain conditions, cluster headache represents one of the most severe. Targeted therapies for cluster headache...

    María Dolores Villar-Martínez, Francesca Puledda, Peter J. Goadsby in Current Treatment Options in Neurology
    Article Open access 23 November 2020
  17. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments

    Acute myeloid leukemia (AML) is a heterogeneous disease linked to a broad spectrum of molecular alterations, and as such, long-term disease control...

    Naval Daver, Ahmad S. Alotaibi, ... Marion Subklewe in Leukemia
    Article Open access 05 May 2021
  18. Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in patients with COVID-19 infection: is there a link? A systematic review and case report analysis

    During the SARS-CoV2 pandemic, several cases of Posterior Reversible Encephalopathy Syndrome (PRES) and of Reversible Cerebral Vasoconstriction...

    Adriano Bonura, Gianmarco Iaccarino, ... Fabio Pilato in Journal of Neurology
    Article 04 April 2023
  19. New pharmacotherapy options for noninfectious posterior uveitis

    Introduction

    Noninfectious inflammation of the posterior eye segment represents an important cause of visual impairment. It often affects relatively...

    Uwe Pleyer, Piergiorgio Neri, Christoph Deuter in International Ophthalmology
    Article Open access 25 February 2021
Did you find what you were looking for? Share feedback.